GHK-Cu (Glycyl-L-Histidyl-L-Lysine:Copper(II)) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. Unlike many research peptides that are entirely synthetic constructs, GHK-Cu is endogenously present in the human body — with plasma concentrations declining significantly with age, prompting research interest in its role in tissue maintenance, wound healing, and skin biology.
This article provides a structured research overview for Australian researchers — for laboratory reference purposes only.
Molecular Identity
- Full name: Glycyl-L-Histidyl-L-Lysine:Copper(II) complex
- Peptide sequence: Gly-His-Lys
- Copper coordination: GHK forms a high-affinity Cu²⁺ complex via the histidine imidazole ring and terminal amino groups
- MW (peptide alone): 340.38 g/mol
- MW (GHK-Cu complex): ~403.91 g/mol
- CAS (GHK): 49557-75-7 | CAS (GHK-Cu): 89030-95-5
The copper moiety is integral to GHK-Cu’s biological activity — GHK alone (without copper) shows significantly reduced activity in collagen synthesis and gene modulation studies, underscoring that the metal-peptide complex is the active research entity.
Proposed Mechanisms of Action
1. Collagen and Extracellular Matrix Synthesis
GHK-Cu is among the most extensively studied cosmetic peptides for extracellular matrix remodelling. Research has demonstrated stimulation of collagen types I, III, and V synthesis, decorin production, and fibronectin expression in fibroblast cultures. These effects are proposed to occur through modulation of TGF-β signalling pathways and direct fibroblast gene transcription activation. The simultaneous upregulation of multiple collagen types distinguishes GHK-Cu from single-collagen-type interventions.
2. Broad Gene Expression Modulation (4,000+ Genes)
One of the most notable findings in GHK-Cu research is the breadth of its proposed gene expression influence. Studies examining GHK-Cu’s effect on human gene expression have identified modulation of over 4,000 human genes — including many associated with anti-inflammatory pathways, tissue repair, antioxidant defence, ubiquitin-proteasome regulation, and metabolic function. This broad genomic footprint distinguishes GHK-Cu from more targeted synthetic peptides and has prompted research interest in its potential applications across multiple biological systems.
3. Antioxidant and Anti-inflammatory Activity
GHK-Cu demonstrates antioxidant properties via copper-mediated free radical scavenging and modulates inflammatory signalling by suppressing the acute-phase inflammatory response. Research in wound models suggests it may attenuate TGF-β1-driven scar formation while maintaining the regenerative tissue repair signal — a property of interest for studies examining the balance between repair and fibrosis.
4. Angiogenesis
Consistent with other tissue-repair research peptides (BPC-157, TB-500), GHK-Cu has been associated with angiogenic effects in preclinical models, including VEGF pathway activation. The copper component may directly influence endothelial cell behaviour, with copper being a known co-factor in angiogenic enzyme systems.
Key Research Findings (2023–2026)
2023 Double-Blind Skin Firmness Trial
A double-blind, split-face randomised study (n=60, aged 40–65 years) evaluated a 0.05% GHK-Cu topical serum versus placebo for 12 weeks. Optical profilometry measurements showed a 22% increase in skin firmness and a 16% reduction in fine-line depth in the active treatment group. This represents the most rigorous recent human skin biology dataset for topical GHK-Cu.
2016–2025 Comprehensive Wound Healing Review
A comprehensive literature review published in Medical Sciences examined tripeptides in wound healing and skin regeneration across studies from 2016–2025. The review identified GHK-Cu’s extracellular matrix modulation, angiogenesis promotion, and inflammation control as the three most consistently supported research mechanisms across study types.
Active Clinical Trial (2026)
A Phase II clinical trial (ClinicalTrials.gov NCT07437586) was registered in 2026 to evaluate a topical GHK-Cu gel for acute skin wound healing in healthy adults — representing the first prospective, controlled wound-closure trial of this type for GHK-Cu.
Research Applications
- Skin and dermal biology — collagen synthesis, fibroblast gene expression, ECM remodelling studies
- Wound healing models — wound closure rate, scar formation, anti-inflammatory mechanisms
- Cosmetic peptide research — skin firmness, fine-line reduction, barrier function
- Antioxidant biology — copper-mediated reactive oxygen species scavenging mechanisms
- Gene expression studies — broad genomic footprint with 4,000+ modulated genes
- Anti-fibrotic research — scar modulation and TGF-β1 pathway studies
GHK-Cu vs Other Cosmetic Research Peptides
| Peptide | Mechanism | Primary Research Focus |
|---|---|---|
| GHK-Cu | Copper-mediated collagen synthesis, 4,000+ gene modulation | Skin ECM, wound healing, antioxidant |
| Argireline (Acetyl Hexapeptide-3) | SNARE protein inhibition (acetylcholine-like) | Expression line reduction (neuromuscular) |
| Matrixyl (Palmitoyl Pentapeptide-4) | TGF-β pathway stimulation | Collagen I and III synthesis |
| Syn-Ake | Nicotinic acetylcholine receptor antagonism (snake venom analogue) | Muscle contraction reduction models |
| Melanotan I/II | MC1R/MC3R agonism | Melanogenesis, photoprotection models |
Storage and Light Sensitivity
GHK-Cu contains a tyrosine-adjacent sequence and the copper complex is sensitive to oxidation. Store lyophilised GHK-Cu at −20°C in an amber vial, protected from light and moisture. Once reconstituted with bacteriostatic water, store at 2–8°C and use within 4 weeks. Protect from direct laboratory lighting during handling. See the full peptide storage guide →
Browse GHK-Cu and cosmetic research peptides →
Frequently Asked Questions
What is GHK-Cu and where does it occur naturally?
GHK-Cu is a tripeptide (Gly-His-Lys) copper complex found naturally in human plasma, saliva, and urine. Plasma concentrations of GHK decline from approximately 200 ng/mL in young adults to around 80 ng/mL by age 60, prompting research interest in its role in tissue maintenance and the biology of ageing.
How does GHK-Cu affect collagen synthesis in research models?
GHK-Cu stimulates synthesis of collagen types I, III, and V in fibroblast models, along with decorin and fibronectin production. These effects are proposed to occur through modulation of TGF-β signalling pathways and direct activation of fibroblast gene transcription, producing a broader ECM remodelling signal than most single-collagen-target peptides.
How many genes does GHK-Cu modulate in research?
Studies examining GHK-Cu’s effect on human gene expression have identified modulation of over 4,000 human genes, including those associated with anti-inflammatory pathways, tissue repair, antioxidant defence, and metabolic regulation. This broad genomic footprint is among the most distinctive characteristics of GHK-Cu compared to more targeted research peptides.
Is GHK-Cu legal to purchase for research in Australia?
Yes. GHK-Cu is not scheduled under the TGA Poisons Standard and is legally available in Australia for laboratory and research use. It is widely used in cosmetic peptide research. It is not approved for therapeutic use and must not be used for human or veterinary consumption outside of a research context.
How should GHK-Cu be stored in a research setting?
Lyophilised GHK-Cu should be stored at −20°C in an amber (light-protecting) vial, as the copper complex is susceptible to photo-oxidation. Once reconstituted with bacteriostatic water, refrigerate at 2–8°C and use within 4 weeks. Minimise exposure to laboratory lighting during handling.
For laboratory and research use only. Not for human or veterinary consumption. Nothing in this article constitutes medical advice.
